• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症在自身免疫性疾病中的作用:一个治疗靶点。

The role of inflammation in autoimmune disease: a therapeutic target.

机构信息

Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

出版信息

Front Immunol. 2023 Oct 4;14:1267091. doi: 10.3389/fimmu.2023.1267091. eCollection 2023.

DOI:10.3389/fimmu.2023.1267091
PMID:37859999
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10584158/
Abstract

Autoimmune diseases (AIDs) are immune disorders whose incidence and prevalence are increasing year by year. AIDs are produced by the immune system's misidentification of self-antigens, seemingly caused by excessive immune function, but in fact they are the result of reduced accuracy due to the decline in immune system function, which cannot clearly identify foreign invaders and self-antigens, thus issuing false attacks, and eventually leading to disease. The occurrence of AIDs is often accompanied by the emergence of inflammation, and inflammatory mediators (inflammatory factors, inflammasomes) play an important role in the pathogenesis of AIDs, which mediate the immune process by affecting innate cells (such as macrophages) and adaptive cells (such as T and B cells), and ultimately promote the occurrence of autoimmune responses, so targeting inflammatory mediators/pathways is one of emerging the treatment strategies of AIDs. This review will briefly describe the role of inflammation in the pathogenesis of different AIDs, and give a rough introduction to inhibitors targeting inflammatory factors, hoping to have reference significance for subsequent treatment options for AIDs.

摘要

自身免疫性疾病(AIDs)是一种免疫紊乱,其发病率和患病率逐年上升。AIDs 是由免疫系统错误识别自身抗原引起的,看似是由于免疫功能过度引起的,但实际上是由于免疫系统功能下降导致的准确性降低,无法清晰识别外来入侵者和自身抗原,从而发出虚假攻击,最终导致疾病。AIDs 的发生通常伴随着炎症的出现,炎症介质(炎症因子、炎性小体)在 AIDs 的发病机制中起着重要作用,通过影响先天细胞(如巨噬细胞)和适应性细胞(如 T 和 B 细胞)来调节免疫过程,最终促进自身免疫反应的发生,因此针对炎症介质/途径是 AIDs 新兴治疗策略之一。本文将简要描述炎症在不同 AIDs 发病机制中的作用,并对靶向炎症因子的抑制剂进行简要介绍,以期对后续 AIDs 的治疗选择具有参考意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/2b2ba73cbdc8/fimmu-14-1267091-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/b20ab6c4ea38/fimmu-14-1267091-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/f3644cde115d/fimmu-14-1267091-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/bc7cd2853ae3/fimmu-14-1267091-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/76cc8ab9bc5c/fimmu-14-1267091-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/04bc70fa9b16/fimmu-14-1267091-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/8190ec486515/fimmu-14-1267091-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/251c6fb9e309/fimmu-14-1267091-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/2b2ba73cbdc8/fimmu-14-1267091-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/b20ab6c4ea38/fimmu-14-1267091-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/f3644cde115d/fimmu-14-1267091-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/bc7cd2853ae3/fimmu-14-1267091-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/76cc8ab9bc5c/fimmu-14-1267091-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/04bc70fa9b16/fimmu-14-1267091-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/8190ec486515/fimmu-14-1267091-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/251c6fb9e309/fimmu-14-1267091-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d0/10584158/2b2ba73cbdc8/fimmu-14-1267091-g008.jpg

相似文献

1
The role of inflammation in autoimmune disease: a therapeutic target.炎症在自身免疫性疾病中的作用:一个治疗靶点。
Front Immunol. 2023 Oct 4;14:1267091. doi: 10.3389/fimmu.2023.1267091. eCollection 2023.
2
Glycolysis in Innate Immune Cells Contributes to Autoimmunity.先天免疫细胞中的糖酵解作用有助于自身免疫。
Front Immunol. 2022 Jul 1;13:920029. doi: 10.3389/fimmu.2022.920029. eCollection 2022.
3
Macrophages: The Good, the Bad, and the Gluttony.巨噬细胞:亦善亦恶亦饕餮。
Front Immunol. 2021 Aug 12;12:708186. doi: 10.3389/fimmu.2021.708186. eCollection 2021.
4
A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.一项评估胆钙化醇补充对桥本甲状腺炎自身免疫可能作用的前瞻性研究。
J Assoc Physicians India. 2023 Jan;71(1):1.
5
Volatile organic compounds: A proinflammatory activator in autoimmune diseases.挥发性有机化合物:自身免疫性疾病中的促炎激活物。
Front Immunol. 2022 Jul 29;13:928379. doi: 10.3389/fimmu.2022.928379. eCollection 2022.
6
From autoinflammation to autoimmunity: old and recent findings.从自身炎症到自身免疫:旧的和新的发现。
Clin Rheumatol. 2018 Sep;37(9):2305-2321. doi: 10.1007/s10067-018-4209-9. Epub 2018 Jul 16.
7
Atherosclerosis and autoimmunity: a growing relationship.动脉粥样硬化与自身免疫:日益紧密的关系。
Int J Rheum Dis. 2018 May;21(5):908-921. doi: 10.1111/1756-185X.13309. Epub 2018 Apr 19.
8
Innate immunity as the trigger of systemic autoimmune diseases.先天免疫作为系统性自身免疫性疾病的触发因素。
J Autoimmun. 2020 Jun;110:102382. doi: 10.1016/j.jaut.2019.102382. Epub 2019 Dec 26.
9
Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity.信号传导、炎症与关节炎:交叉信号:白细胞介素-15和-18在自身免疫中的作用
Rheumatology (Oxford). 2008 Sep;47(9):1269-77. doi: 10.1093/rheumatology/ken257. Epub 2008 Jul 10.
10
The emerging role of regulatory cell-based therapy in autoimmune disease.调节性细胞治疗在自身免疫性疾病中的新作用。
Front Immunol. 2022 Dec 14;13:1075813. doi: 10.3389/fimmu.2022.1075813. eCollection 2022.

引用本文的文献

1
The Anti-Lupus Plate: Mapping Nutritional Interventions to Inflammatory Pathways in Systemic Lupus Erythematosus.抗狼疮板块:系统性红斑狼疮中营养干预与炎症途径的映射
Food Sci Nutr. 2025 Sep 1;13(9):e70890. doi: 10.1002/fsn3.70890. eCollection 2025 Sep.
2
Mechanisms of cancer-induced neurophysiological dysfunction and therapeutic strategies.癌症诱导的神经生理功能障碍机制与治疗策略。
Discov Oncol. 2025 Sep 3;16(1):1678. doi: 10.1007/s12672-025-03520-0.
3
Correlations Between Immuno-Inflammatory Biomarkers and Hematologic Indices Stratified by Immunologic SNP Genotypes.

本文引用的文献

1
Aureane-type sesquiterpene tetraketides as a novel class of immunomodulators with interleukin-17A inhibitory activity.奥雷烷型倍半萜四酮类化合物作为一类具有白细胞介素-17A抑制活性的新型免疫调节剂。
Acta Pharm Sin B. 2023 Sep;13(9):3930-3944. doi: 10.1016/j.apsb.2023.03.017. Epub 2023 Mar 21.
2
Mirikizumab: First Approval.米利珠单抗:首个获批
Drugs. 2023 Jul;83(11):1045-1052. doi: 10.1007/s40265-023-01909-1.
3
Comparation of time-course, dose-effect, influencing factors and adverse events of biologics in the treatment of adults with moderate to severe plaque psoriasis.
免疫炎症生物标志物与按免疫单核苷酸多态性(SNP)基因型分层的血液学指标之间的相关性
J Clin Med. 2025 Aug 15;14(16):5792. doi: 10.3390/jcm14165792.
4
The next frontier in antibody-drug conjugates: challenges and opportunities in cancer and autoimmune therapy.抗体药物偶联物的下一个前沿领域:癌症与自身免疫疗法中的挑战与机遇
Cancer Drug Resist. 2025 Jul 3;8:34. doi: 10.20517/cdr.2025.49. eCollection 2025.
5
Immunomodulatory Effects of LSI312A on Dendritic Cells: A Novel Approach to Modulating Inflammatory Pathways.LSI312A对树突状细胞的免疫调节作用:调节炎症通路的新方法。
J Microbiol Biotechnol. 2025 Aug 18;35:e2506027. doi: 10.4014/jmb.2506.06027.
6
Roles of chemical species transport and transformation in the biophysics of human pathophysiology.化学物质的运输和转化在人类病理生理学的生物物理学中的作用。
NPJ Biol Phys Mech. 2025;2(1):20. doi: 10.1038/s44341-025-00025-3. Epub 2025 Aug 6.
7
Engineering B cells to Express Fully Customizable Antibodies with Enhanced Fc Functions.工程化B细胞以表达具有增强Fc功能的完全可定制抗体。
bioRxiv. 2025 Jul 27:2025.07.23.666432. doi: 10.1101/2025.07.23.666432.
8
Lysosomal membrane homeostasis and its importance in physiology and disease.溶酶体膜稳态及其在生理和疾病中的重要性。
Nat Rev Mol Cell Biol. 2025 Aug 4. doi: 10.1038/s41580-025-00873-w.
9
GLP-1 and Its Role in Glycogen Production: A Narrative Review.胰高血糖素样肽-1及其在糖原生成中的作用:一篇叙述性综述。
Biomedicines. 2025 Jun 30;13(7):1610. doi: 10.3390/biomedicines13071610.
10
SGLT2 inhibitors in autoimmune diseases: emerging therapeutic potential and clinical challenges.钠-葡萄糖协同转运蛋白2抑制剂在自身免疫性疾病中的应用:新出现的治疗潜力与临床挑战
Front Immunol. 2025 Jul 3;16:1589341. doi: 10.3389/fimmu.2025.1589341. eCollection 2025.
比较生物制剂治疗成人中重度斑块型银屑病的时间进程、剂量效应、影响因素和不良反应。
Front Immunol. 2023 May 25;14:1151977. doi: 10.3389/fimmu.2023.1151977. eCollection 2023.
4
Potential angiogenic, immunomodulatory, and antifibrotic effects of mesenchymal stem cell-derived extracellular vesicles in systemic sclerosis.间充质干细胞来源的细胞外囊泡在系统性硬化症中的潜在血管生成、免疫调节和抗纤维化作用。
Front Immunol. 2023 May 12;14:1125257. doi: 10.3389/fimmu.2023.1125257. eCollection 2023.
5
PKM2 promotes proinflammatory macrophage activation in ankylosing spondylitis.PKM2 促进强直性脊柱炎中促炎型巨噬细胞的激活。
J Leukoc Biol. 2023 Nov 24;114(6):595-603. doi: 10.1093/jleuko/qiad054.
6
Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis.一项关于替度鲁单抗治疗中重度银屑病患者的 4 期真实世界研究的生活质量和患者报告症状:第 28 周中期分析。
J Dermatolog Treat. 2023 Dec;34(1):2200872. doi: 10.1080/09546634.2023.2200872.
7
Pathogenesis of autoimmune disease.自身免疫性疾病的发病机制。
Nat Rev Nephrol. 2023 Aug;19(8):509-524. doi: 10.1038/s41581-023-00720-1. Epub 2023 May 10.
8
Unique structure of ozoralizumab, a trivalent anti-TNFα NANOBODY compound, offers the potential advantage of mitigating the risk of immune complex-induced inflammation.奥扎鲁单抗的独特结构是一种三价抗 TNFα 的纳米体药物复合物,具有减轻免疫复合物引起的炎症风险的潜在优势。
Front Immunol. 2023 Apr 14;14:1149874. doi: 10.3389/fimmu.2023.1149874. eCollection 2023.
9
Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα NANOBODY compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials.奥扎鲁单抗,一种抗 TNFα NANOBODY 化合物,在类风湿关节炎患者中的疗效和药代动力学:OHZORA 和 NATSUZORA 试验的 52 周结果。
Arthritis Res Ther. 2023 Apr 13;25(1):60. doi: 10.1186/s13075-023-03036-4.
10
Inflammation and malnutrition in inflammatory bowel disease.炎症性肠病中的炎症和营养不良。
Lancet Gastroenterol Hepatol. 2023 Jun;8(6):579-590. doi: 10.1016/S2468-1253(23)00011-0. Epub 2023 Mar 15.